$INJ bounced 10% as its ETF story heats up: 21Shares and Canary both amended spot INJ ETF filings with the SEC in September.
Injective is a DeFi layer-1. An ETF would bring TradFi demand to INJ.
Long: buy 7.50-7.65 on a retest. Targets 8.20 / 8.69. Dead below 6.94 daily close. Risk: approval is never guaranteed.
Long the retest or wait for a deeper dip? Pick one.
Not financial advice. DYOR.
Injective is a DeFi layer-1. An ETF would bring TradFi demand to INJ.
Long: buy 7.50-7.65 on a retest. Targets 8.20 / 8.69. Dead below 6.94 daily close. Risk: approval is never guaranteed.
Long the retest or wait for a deeper dip? Pick one.
Not financial advice. DYOR.